Marek Vasicek
About Marek Vasicek
Marek Vasicek is the Transformation Lead CEE, Turkey Greece Israel/Interim Managing Director Australia & New Zealand at Bristol Myers Squibb, with extensive experience in market access and health economics.
Current Roles at Bristol Myers Squibb
Marek Vasicek currently holds the positions of Transformation Lead for CEE, Turkey, Greece, and Israel, and is the Interim Managing Director for Australia & New Zealand at Bristol Myers Squibb. His dual roles span multiple regions, reflecting a broad scope of responsibilities in both Europe and Oceania. He operates out of Prague, Czechia, and Melbourne, Australia.
Previous Experience at Bristol Myers Squibb
Marek Vasicek has an extensive history with Bristol Myers Squibb, having held various high-level positions. He served as General Manager in Moscow, Russia from 2016 to 2021, and Executive Director for International Markets handling COVID monoclonal antibodies from 2021 to 2022. His tenure included pivotal roles such as Interim General Manager in Shanghai, China in 2019, and Director of Business Development and Alliances Management in Moscow from 2013 to 2014.
Educational Background
Marek Vasicek has a rich educational background. He obtained his MBA in Business Administration from The University of Manchester in 2000, and studied General Management at INSEAD and achieved CEDEP in 2012. He also completed management studies at the Stockholm School of Economics in 2010. Earlier in his career, he earned a Medical Doctor degree in General Medicine from Univerzita Karlova v Praze in 1994.
Proficiency and Specialization
Marek Vasicek is fluent in Czech, Slovak, English, and Russian, with intermediate proficiency in German and French. His specialization lies in launch effectiveness for pharmaceuticals and OTC products, particularly in therapeutic areas such as oncology, immuno-oncology, virology, diabetes, and cardiology. He has demonstrated strong leadership and people development skills throughout his career.
Leadership and Revenue Management
In his career, Marek Vasicek has managed significant revenues and large teams. He led a team of over 200 employees in Russia, achieving an annual revenue of $400M in the oncology and specialty care sector. He directed commercial operations in Russia with a scope of $130M annual turnover and 80 employees from 2009 to 2014, and managed Czech Republic operations with a $30M annual turnover from 2006 to 2008.